Co-Diagnostics Stock (NASDAQ:CODX)
Previous Close
$1.06
52W Range
$1.00 - $2.23
50D Avg
$1.22
200D Avg
$1.22
Market Cap
$32.25M
Avg Vol (3M)
$195.15K
Beta
-0.85
Div Yield
-
CODX Company Profile
Co-Diagnostics, Inc., a molecular diagnostics company, develops, manufactures, and sells reagents used for diagnostic tests that function through the detection and/or analysis of nucleic acid molecules in the United States and internationally. It offers polymerase chain reaction (PCR) diagnostic tests for COVID-19, tuberculosis, hepatitis B and C, human papilloma virus, malaria, chikungunya, dengue, and the zika virus; three multiplexed tests to test mosquitos for the identification of diseases carried by the mosquitos; and molecular tools for detection of infectious diseases, liquid biopsy for cancer screening, and agricultural applications. The company also provides tests that identify genetic traits in plant and animal genomes; and portable PCR device designed to bring PCR to patients in point-of-care and at-home settings. In addition, it intends to sell diagnostic equipment from other manufacturers as self-contained lab systems. The company was incorporated in 2013 and is headquartered in Salt Lake City, Utah.
CODX Performance
Peer Comparison
| Ticker | Company |
|---|---|
| BMRA | Biomerica, Inc. |
| NURO | NeuroMetrix, Inc. |
| RPID | Rapid Micro Biosystems, Inc. |
| INVO | INVO Bioscience, Inc. |
| TIVC | Tivic Health Systems, Inc. |
| NVNO | enVVeno Medical Corporation |
| MOVE | Movano Inc. |
| CLPT | ClearPoint Neuro, Inc. |
| NPCE | NeuroPace, Inc. |
| SRDX | Surmodics, Inc. |
| IINN | Inspira Technologies Oxy B.H.N. Ltd. |
| OPGN | OpGen, Inc. |
| RSLS | ReShape Lifesciences Inc. |
| BBLG | Bone Biologics Corporation |
| BJDX | Bluejay Diagnostics, Inc. |
| HSCS | Heart Test Laboratories, Inc. |
| INGN | Inogen, Inc. |
| CVRX | CVRx, Inc. |
| VVOS | Vivos Therapeutics, Inc. |
| NAOV | NanoVibronix, Inc. |